MISSION AND VISION

Our mission and vision are to revolutionize drug discovery and development of heart therapeutics with our suite of proprietary bioengineered human heart constructs, and to further develop them into transplantable grafts for cell-based regenerative heart therapies with superior safety and efficacy.


Make A Heart, Save A Heart

Founded in 2014, Novoheart has the longest history in commercializing human cardiac tissue engineering for disease modeling and drug screening. Our founders were among the first-generation biomedical engineers who started the fields back in the late 90s. Novoheart has the industry’s most sophisticated and comprehensive human cardiac tissue engineering platform and the only Human-Heart-in-a-Jar.


Novoheart was previously dually publicly-listed on the Toronto Stock Exchange and Frankfurt Stock Exchange before its acquisition and privatisation by the Medera group in 2020. The merger allows Novoheart as a Medera portfolio company to have access to highly specialised expertise in clinical trials from IND applications to patient enrolment as well as advanced cGMP manufacturing of gene and cell products for patients, providing a one-stop platform for Novoheart as well as its clients and partners.

Heart Disease

Heart Disease

The top killer globally, with 17.5 million deaths each year;

accounts for over 30% of all deaths worldwide


Management Team

Every member of our management team is a thought leader who has made significant contributions to our society. Each one brings a unique set of skills and expertise to our organization. 

EXECUTIVE MANAGEMENT TEAM

Ronald Li, PhD

Chief Executive Officer and Scientific co-founder

Kevin Costa, PhD

Chief Science Officer and  Scientific Co-founder 


Sue Kim, MBA

Financial Controller

Erin Roberts, PhD

Senior Vice President of Research and Development

Isuru Karunaratne, PhD

Bioengineering Lead

Erica Mak

Stem Cell Lead

Deborah K. Lieu, PhD

Senior Scientific Consultant

Hiro Watanabe

Head of Operations

SCIENCE ADVISORY BOARD

Roger Hajjar, MD

Scientific Advisory Board
Chair

Leslie Tung, PhD

Scientific Advisory Board Member

Mark Mercola, PhD 

Scientific Advisory Board
Member

Michelle Khine, PhD

Scientific Advisory Board Member and Scientific Co-Founder

Share by: